Dr Sarah Harbach
+61 3 8344 5773 | sarah.harbach@unimelb.edu.au
- Position:
- Research Fellow
- Theme(s):
- Viral Infectious Diseases, Bacterial and Parasitic Infections
- Discipline(s):
- Discovery Research, Public Health, Clinical and health systems research
- Unit(s):
- The University of Melbourne, Department of Infectious Diseases, The Royal Melbourne Hospital, Victorian Infectious Diseases Reference Laboratory (VIDRL)
- Lab Group(s):
- Vincan Group
Dr Sarah Harbach is a junior postdoctoral research fellow in the Vincan-Tran research group co-headed by Professor Elizabeth Vincan and Dr Hoanh Tran, and a medical scientist in VIDRL’s Tissue Culture Based Diagnostics (TCBD) Laboratory, headed by Professor Elizabeth Vincan. Sarah completed her PhD at the University of Manchester (UK) in 2023, identifying nasal biomarkers of lung cancer and investigating the nasal epithelial response in COVID-19 using shotgun proteomics. Through her PhD and her time at AstraZeneca (UK) analysing the biodistribution of lipid nanoparticles, Sarah has extensive experience in mass spectrometry analysis of small molecules, lipids and proteins, and the nasal proteomic landscape in lung cancer and COVID-19.
-
Key Achievements
Research Groups
-
Identified novel nasal proteomic alterations in acute SARS-CoV-2 and post-infection recovery.
Identified nasal biomarkers of lung cancer applicable to screening programs; Sarah has a patent for these biomarkers.
-
Vincan Group
Elizabeth’s group investigates novel ways to block cancer growth with a focus on the gastrointestinal tract – stomach, bowel and liver. A cell-cell communication pathway called Wnt is hyperactive in these cancers. Their research shows inhibiting Wnt has potent anti-cancer effects.
Lab Team
-
Medical Scientist / Laboratory Head
-
Research Fellow
-
Joint Laboratory Head, Senior Research Fellow
-
Jean MoselenResearch Fellow
-
Research Fellow
-
Research Fellow
-
-